The body of evidence supporting DCP as a potential biomarker for HCC is still growing, as DCP levels are not only correlated with HCC stage and survival, but DCP may be more sensitive than AFP for HCC detection [223, 224]. The gene discussed is ACE; the disease is hepatocellular carcinoma.